Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 24, 2026
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma.
Journal: Neoplasia (New York, N.Y.)
Published: November 28, 2025
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 05, 2025
Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas.
Journal: Cancers
Published: June 06, 2022
Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma.
Journal: Pediatric blood & cancer
Published: December 31, 2020
Showing 1-7 of 7
Last Updated: 09/26/2026